ALEXIS SALVA: Open Payments
NPI 1417411315 · KANSAS CITY, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$381 in 10 payments from 8 companies in 2025. Trend: 2023 $385 · 2024 $607 · 2025 $381
Food & beverage: $381
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 2 | $154 |
| Amgen Inc. | 1 | $87 |
| Novo Nordisk Inc | 2 | $35 |
| Lilly USA, LLC | 1 | $26 |
| Esperion Therapeutics, Inc. | 1 | $23 |
| Abbott Laboratories | 1 | $22 |
| Mannkind Corporation | 1 | $17 |
| Sequel Med Tech, LLC | 1 | $16 |
Products named: Dexcom G6 Transmitter, EVENITY, Ozempic, MOUNJARO, NEXLETOL, FREESTYLE LIBRE 3, AFREZZA, TWIIST.
Industry payments across KS — which companies pay providers there.
